Long-term effects of an Apocynum venetum extract on brain monoamine levels and β-AR density in rats

被引:47
作者
Butterweck, V
Simbrey, K
Seo, S
Sasaki, T
Nishibe, S
机构
[1] Univ Klinikum Muenster, Inst Pharmacol & Toxicol, D-48149 Munster, Germany
[2] Tokiwa Phytochem Co Ltd, Sakura, Chiba 2850801, Japan
[3] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Hokkaido 0610293, Japan
关键词
Apocynum venetum; antidepressant; serotonin; dopamine; norepinephrine; beta-receptor regulation;
D O I
10.1016/S0091-3057(03)00118-7
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The present study was designed to get further insight into the mode of antidepressant action of an extract prepared of the leaves of Apocynum venetum L. (AV). To evaluate biochemical changes, we used a high-performance liquid chromatography system to examine the effects of short-term (2 weeks) and long-term (8 weeks) administration of imipramine (15 mg/kg po) and an AV-extract (15, 60 and 250 mg/kg) on regional levels of serotonin (5-HT), norepinephrine (NE), dopamine (DA) and their metabolites in the rat hypothalamus, striatum and hippocampus. Pronounced changes in 5-HT, NE and DA levels were detected mainly after 8 weeks of daily imipramine treatment. Similar to imipramine, AV-extract reduced NE and DA concentrations after 8 weeks, whereas it failed to affect 5-HT levels. We speculate that the decrease in NE levels after chronic AV treatment might be based partly on the subsensitivity of presynaptic alpha(2)-receptors. In addition to the determination of central monoamine concentrations, quantitative radioligand receptor-binding studies were used to examine the effects of long-term administration of imipramine and AV-extract on beta-adrenergic binding in rat frontal cortex. [I-125]CYP binding to beta-adrenergic receptors was found to be decreased after 8 weeks treatment with imipramine, whereas AV-extract had no effect on beta-receptor binding. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:557 / 564
页数:8
相关论文
共 51 条
[1]   The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram [J].
Arborelius, L ;
Nomikos, GG ;
Hertel, P ;
Salmi, P ;
Grillner, P ;
Hook, BB ;
Hacksell, U ;
Svensson, TH .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 353 (06) :630-640
[2]   RAPID DOWN REGULATION OF BETA-ADRENOCEPTORS BY CO-ADMINISTRATION OF DESIPRAMINE AND FLUOXETINE [J].
BARON, BM ;
OGDEN, AM ;
SIEGEL, BW ;
STEGEMAN, J ;
URSILLO, RC ;
DUDLEY, MW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 154 (02) :125-134
[3]   THE ANTIDEPRESSANTS FLUOXETINE, IDAZOXAN AND PHENELZINE ALTER CORTICOTROPIN-RELEASING HORMONE AND TYROSINE-HYDROXYLASE MESSENGER-RNA LEVELS IN RAT-BRAIN - THERAPEUTIC IMPLICATIONS [J].
BRADY, LS ;
GOLD, PW ;
HERKENHAM, M ;
LYNN, AB ;
WHITFIELD, HJ .
BRAIN RESEARCH, 1992, 572 (1-2) :117-125
[4]   LONG-TERM ANTIDEPRESSANT ADMINISTRATION ALTERS CORTICOTROPIN-RELEASING HORMONE, TYROSINE-HYDROXYLASE, AND MINERALOCORTICOID RECEPTOR GENE-EXPRESSION IN RAT-BRAIN - THERAPEUTIC IMPLICATIONS [J].
BRADY, LS ;
WHITFIELD, HJ ;
FOX, RJ ;
GOLD, PW ;
HERKENHAM, M .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) :831-837
[5]   Long-term effects of St. John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus [J].
Butterweck, V ;
Böckers, T ;
Korte, B ;
Wittkowski, W ;
Winterhoff, H .
BRAIN RESEARCH, 2002, 930 (1-2) :21-29
[6]   Antidepressant effects of Apocynum venetum leaves in a forced swimming test [J].
Butterweck, V ;
Nishibe, S ;
Sasaki, T ;
Uchida, M .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (07) :848-851
[7]   St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats [J].
Butterweck, V ;
Winterhoff, H ;
Herkenham, M .
MOLECULAR PSYCHIATRY, 2001, 6 (05) :547-564
[8]  
Chung Moon Yong, 1993, Yonsei Medical Journal, V34, P266
[9]  
Delgado PL, 2000, J CLIN PSYCHIAT, V61, P7
[10]  
DIGORY GL, 1984, EUR J PHARMACOL, V105, P257